AG
AGT.F AptarGroup Inc
- Market cap
- EUR 8.11B
- P/E
- 35.6x
- P/B
- 3.46x
- ROE
- 8.1%
- Dividend yield
- 1.42%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is AGT.F undervalued?
Graham numberAGT.F trades 134.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
AptarGroup Inc fundamental analysis
No fundamental analysis for AptarGroup Inc yet.
AptarGroup Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About AptarGroup Inc
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical…
Full company profileAptarGroup Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
AptarGroup Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.33B | 2.47B | 2.76B | 2.86B | 2.93B | 3.23B | 3.32B | 3.49B | 3.58B | 3.78B | 4.00B |
| Gross Profit | 833M | 865M | 952M | 1.04B | 1.09B | 1.16B | 1.16B | 1.26B | 1.36B | 1.40B | 1.45B |
| Operating Income | 311M | 324M | 350M | 392M | 366M | 371M | 386M | 449M | 509M | 511M | 492M |
| EBITDA | - | 489M | 470M | 572M | 555M | 587M | 609M | 664M | 777M | 831M | 676M |
| Net Income | 206M | 220M | 195M | 242M | 214M | 244M | 239M | 284M | 375M | 393M | 211M |
| EPS | - | 3.56 | 3.10 | 3.80 | 3.29 | 3.73 | 3.67 | 4.32 | 5.63 | 6.12 | 3.32 |
| Balance Sheet | |||||||||||
| Total Assets | 2.61B | 3.14B | 3.38B | 3.56B | 3.99B | 4.14B | 4.20B | 4.45B | 4.43B | 5.25B | 5.11B |
| Total Liabilities | 1.43B | 1.83B | 1.95B | 1.99B | 2.14B | 2.16B | 2.14B | 2.13B | 1.95B | 2.54B | 2.45B |
| Shareholders' Equity | 1.17B | 1.31B | 1.42B | 1.57B | 1.85B | 1.97B | 2.05B | 2.31B | 2.47B | 2.67B | 2.61B |
| Cash & Short-term Investments | 466M | 713M | 262M | 242M | 300M | 123M | 142M | 224M | 224M | 402M | 204M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 325M | 325M | 314M | 514M | 570M | 363M | 479M | 528M | 643M | 570M | - |
| Capital Expenditure | 131M | 157M | 211M | 242M | 246M | 308M | 310M | 319M | 294M | 275M | 181M |
| Free Cash Flow | - | 168M | 102M | 267M | 318M | 55.5M | 163M | 209M | 349M | 295M | - |
| Ratios | |||||||||||
| ROE | 17.5% | 16.8% | 13.7% | 15.4% | 11.6% | 12.4% | 11.7% | 12.3% | 15.2% | 14.7% | 8.1% |
| ROA | 7.9% | 7.0% | 5.8% | 6.8% | 5.4% | 5.9% | 5.7% | 6.4% | 8.5% | 7.5% | 4.1% |
| Net Profit Margin | 8.8% | 8.9% | 7.0% | 8.5% | 7.3% | 7.6% | 7.2% | 8.2% | 10.5% | 10.4% | 5.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
AptarGroup Inc dividends
- Dividend yield
- 1.42%
- Forward dividend
- 1.79 EUR
- Payout ratio
- 30.8%
- Ex-dividend date
- Nov 12, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 121M | 1.88 | 30.8% |
| 2024 | USD 114M | 1.72 | 30.5% |
| 2023 | USD 102M | 1.54 | 35.7% |
| 2022 | USD 99.5M | 1.53 | 41.6% |
| 2021 | USD 98.5M | 1.50 | 40.4% |
| 2020 | USD 92.7M | 1.43 | 43.3% |
| 2019 | USD 90.2M | 1.41 | 37.2% |
| 2018 | USD 82.3M | 1.31 | 42.3% |
| 2017 | USD 79.9M | 1.29 | 36.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns AptarGroup Inc
- Insiders 0.86%
- Institutions 99.14%
- Public & others 0.00%
- Shares outstanding 63.4M
- Free float 62.8M
AptarGroup Inc company profile
- Company name
- AptarGroup Inc
- Ticker
- AGT.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 14,000
- Fiscal year end
- December
- Address
- 265 Exchange Drive, Crystal Lake, IL, United States, 60014
- Phone
- 815 477 0424
- Website
- aptar.com
About AptarGroup Inc
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
AptarGroup Inc management
10- Mr. Gael TouyaCEO, President & Director · born 1970
- Ms. Vanessa KanuExecutive VP & CFO · born 1978
- Mr. Stephan B. TandaDirector & Advisor · born 1965
- Mr. Marc PrieurPresident of Aptar Beauty · born 1966
- Ms. Xiangwei GongExecutive VP of Strategic Group Development & President of Aptar Asia · born 1970
- Mr. Hedi TliliPresident of Aptar Closures · born 1975
- Mr. Daniel Richard AckermanSenior VP, Interim Chief Accounting Officer & Principal Accounting Officer · born 1973
- Ms. Mary SkafidasSenior Vice President of Investor Relations & Communications
- Ms. Irene HudsonExecutive VP, Chief Legal Officer & Corporate Secretary · born 1977
- Ms. Shiela Pallerne VinczellerChief Human Resources Officer · born 1964